RIVM publishes new data from manufacturers on tobacco products On behalf of the Dutch Ministry of VWS (Health, Welfare and Sport), RIVM has published new data on tobacco products. For the first time, these data include the ingredients of e-cigarettes, heated tobacco products and herbal smoking products.
No indication that investigated mesh implants used to treat pelvic organ prolapse are unsafe RIVM has conducted a laboratory study into six mesh implants from different manufacturers used in the Netherlands in 2018. The study revealed no indication that these products are unsafe for patients.
Exposure to combination of chemicals appears to be too high, health risks unclear The food and drinking water that people consume include chemicals that have effects on health. Among them are substances, such as lead, which are known to have a negative effect on intelligence or development of the brain.
RIVM backs Vaccination Alliance Blokhuis As of yesterday RIVM participates in the Vaccination Alliance initiated by the Dutch State Secretary, Paul Blokhuis, Other members of this Alliance include paediatricians and nurses, general
Improving integrated care requires trust, a small-scale approach and a shared vision To improve integrated care for older people, professionals and organisations need to get to know each other, build trust and better understanding.
Slightly fewer adult smokers In 2018, 22.4 per cent of the Dutch adult population indicated they were occasional smokers.
Slightly more tuberculosis patients in the Netherlands The key figures of the National Institute for Public Health and the Environment (RIVM) show that in 2018 there were 806 TB patients in the Netherlands. This is 3 percent more than in 2017 (784).
Join our HEVnet laboratory network now! Would you like to collaborate in an international laboratory network of hepatitis E virus (HEV) experts performing supranational studies and are you able to share HEV sequences in a shared reposito
Vaccination against meningococcal disease starts for teens aged 14 to 18 This spring, about 860,000 young people in the Netherlands will receive an invitation for a vaccination against meningococcal disease.